Clinical Trials Browser

Phase 2 × EC regimen × Breast × Clear all

NCT05834582 2023-04-28

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT01210768 2021-11-23

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms